General rules are not series-specific; general rules apply to the entire vaccine group.
Rules Based on Patient's Age
|
CVX Code | Name |
---|---|
46 | Hib-PRP-D (ProHIBIT) |
47 | Hib-HbOC (HibTITER) |
48 | Hib-PRP-T (ActHIB, Hiberix) |
49 | Hib-PRP-OMP (PedvaxHIB) |
17 | Hib, unspecified formulation |
CVX Code | Vaccine Name | Component | Component |
---|---|---|---|
22 | DTP-Hib (Tetramune; OmniHib-DTP) | 17 | Hib NOS |
50 | DTaP-Hib (TriHiBit) | 48 | Hib-PRP-T |
51 | Hep B-Hib (PRP-OMP (ComVAX) | 49 | Hib-PRP-OMP |
102 | DTP-Hib-Hep B | 17 | Hib NOS |
120 | DTaP-Hib-IPV | 48 | Hib-PRP-T |
132 | DTaP-IPV-Hib-Hep B, historical | 17 | Hib NOS |
146 | DTaP, IPV, Hib, Hep B | 17 | Hib NOS |
148 | Meningococcal C/Y-HIB PRP (Menhibrix) | 48 | Hib-PRP-T |
170 | DTaP-IPV-Hib | 48 | Hib-PRP-T |
198 | DTP-Hep B-Hib Pentavalent, Non-US | 17 | Hib NOS |
Series Name
Series Selection RulesThere are two series for this vaccine group: the Hib 4-dose series and the Hib OMP series. The rules for determining which series applies are:
|
The Hib 4-dose series is complete after 4 doses, except when one of the Hib 4-dose series exception rules apply.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Hib 4-dose | 38 days | 42 days (6 weeks) | 2 months | 3 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | 501 |
2 | Hib 4-dose | 66 days | 70 days (10 weeks) | 4 months | 5 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | 501 |
3 | Hib 4-dose | 94 days | 98 days (14 weeks) | 6 months | 7 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | 501 |
4 | Hib 4-dose | 1 year - 4 days | 12 months | 12 months | 16 months + 4 weeks | 17, 46, 47, 48, 49, 51, 120, 22, 148, 102, 132, 146, 170, 198 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Hib 4-dose | 24 days | 28 days | 28 days | 16 weeks |
Dose 2 to 3 | Hib 4-dose | 24 days | 28 days | 28 days | 16 weeks |
Dose 3 to 4 | Hib 4-dose | 52 days | 56 days | 56 days | 10 months + 4 weeks |
Series Special RulesHib 4-dose Series Exception RulesFollow the Hib 4-dose series tables (above) unless one of the following exceptions applies:
- Or -
- Or -
Hib 4-dose Series Rule for CVX 50
|
NotesWhile the CDC CDSi rules allow a 4-day grace period for the skip dose trigger ages, the ICE Workgroup has decided not to allow grace periods for skip dose trigger ages. The ICE Workgroup has made this decision because:
|
The Hib OMP series is complete after 3 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Hib OMP | 38 days | 42 days (6 weeks) | 2 months | 3 months + 4 weeks | 49, 51 | 17, 46, 47, 48, 120, 22, 148, 50, 102, 132, 146, 170, 198 |
2 | Hib OMP | 66 days | 70 days (10 weeks) | 4 months | 5 months + 4 weeks | 49, 51 | 17, 46, 47, 48, 120, 22, 148, 50, 102, 132, 146, 170, 198 |
3 | Hib OMP | 1 year - 4 days | 12 months | 12 months | 16 months + 4 weeks | 17, 46, 47, 48, 49, 50, 51, 120, 22, 148, 102, 132, 146, 170, 198 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Hib OMP | 24 days | 28 days | 28 days | 16 weeks |
Dose 2 to 3 | Hib OMP | 52 days | 56 days | 56 days | 10 months + 4 weeks |
Series Special Rules
|